DNA Analysis of Discarded Media Drops From the Clinical IVF Cycles
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03717441 |
Recruitment Status :
Recruiting
First Posted : October 24, 2018
Last Update Posted : February 29, 2024
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Infertility | Diagnostic Test: chromosome numeration of embryos |
Study Type : | Observational [Patient Registry] |
Estimated Enrollment : | 250 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Target Follow-Up Duration: | 2 Months |
Official Title: | DNA Analysis of Discarded Media Drops From the Clinical IVF Cycles |
Actual Study Start Date : | October 22, 2018 |
Estimated Primary Completion Date : | December 15, 2025 |
Estimated Study Completion Date : | June 15, 2026 |
- Diagnostic Test: chromosome numeration of embryos
Use genomic technologies to analyze the discarded media drop for chromosome counting
- DNA Analysis of discarded media drops form the clinical IVF Cycles [ Time Frame: 1 day ]Analyze media drop for presence of DNA to obtain embryo chromosome numeration
Biospecimen Retention: Samples With DNA
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 44 Years (Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Any women undergoing an In Vitro Fertilization cycle (IVF) at the Colorado Center for Reproductive Medicine that is also having Comprehensive Chromosomal Screening (CCS) of embryos
Exclusion Criteria:
-
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03717441
Contact: Rachel Makloski | 303-788-8300 ext 1769 | rmakloski@colocrm.com |
United States, Colorado | |
Colorado Center for Reproductive Medicine | Recruiting |
Lone Tree, Colorado, United States, 80124 | |
Contact: Rachel Makloski, RN rmakloski@colocrm.com |
Principal Investigator: | Mandy Katz-Jaffe, PhD | Colorado Center for Reproductive Medicine |
Responsible Party: | Mandy Katz-Jaffe, PhD, Research Director, Colorado Center for Reproductive Medicine |
ClinicalTrials.gov Identifier: | NCT03717441 |
Other Study ID Numbers: |
2018154 |
First Posted: | October 24, 2018 Key Record Dates |
Last Update Posted: | February 29, 2024 |
Last Verified: | February 2024 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Infertility Genital Diseases Urogenital Diseases |